XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
Three months ended March 31, 2023U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$246,529 $36,461 $140,707 $170,430 $121,874 $716,001 
Service Revenue:
Point in time
70,626 7,461 41,165 11,347 30,045 160,644 
Over time
20,247 2,447 17,552 3,990 7,857 52,093 
Total$337,402 $46,369 $199,424 $185,767 $159,776 $928,738 
Three months ended March 31, 2022U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$248,807 $33,910 $138,009 $167,989 $117,900 $706,615 
Service Revenue:
Point in time
60,154 7,168 36,223 10,327 28,600 142,472 
Over time
16,860 2,192 18,654 4,390 6,608 48,704 
Total$325,821 $43,270 $192,886 $182,706 $153,108 $897,791 
    A breakdown of net sales to external customers by geographic customer destination for the three months ended March 31 follows:
20232022
Americas$372,073 $352,689 
Europe253,974 249,784 
Asia / Rest of World302,691 295,318 
Total$928,738 $897,791 
The Company's global revenue mix by product category is laboratory (56% of sales), industrial (38% of sales) and retail (6% of sales). The Company's product revenue by reportable segment is proportionately similar to the Company's global mix except the Company's Swiss Operations is largely comprised of laboratory products, while the Company's Chinese Operations has a slightly higher percentage of industrial products. A breakdown of the Company’s sales by product category for the three months ended March 31 follows:
20232022
Laboratory$520,031 $513,550 
Industrial355,181 343,738 
Retail53,526 40,503 
Total$928,738 $897,791